Q2 2019 Holdings
Filed 2019-08-14 | 21 holdings | $151.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $26.3K | 330,697 | 17.4% |
| Odonate Therapeutics Inc | COM | 676079106 | $22.6K | 615,850 | 14.9% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $18.9K | 446,905 | 12.5% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $15.2K | 1,726,603 | 10.1% |
| Sutro BioPharma Inc | COM | 869367102 | $12.8K | 1,125,579 | 8.5% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $12.7K | 383,480 | 8.4% |
| Atreca Inc(BCELUSD) | COM | 04965G109 | $11.1K | 591,368 | 7.4% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $8.4K | 376,583 | 5.5% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $5.3K | 658,532 | 3.5% |
| Hookipa Pharma Inc | COM | 43906K100 | $3.6K | 530,245 | 2.4% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $2.7K | 442,733 | 1.8% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6K | 118,500 | 1.7% |
| Catabasis Pharmaceuticals Inc(CATBEUR) | COM | 14875P206 | $2.4K | 300,000 | 1.6% |
| Evelo Biosciences Inc | COM | 299734103 | $2.0K | 227,529 | 1.3% |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | $1.5K | 2,110,913 | 1.0% |
| Urovant Sciences Ltd | COM | G9381B108 | $1.2K | 157,480 | 0.8% |
| Regulus Therapeutics Inc | COM | 75915K200 | $1.1K | 904,407 | 0.7% |
| Millendo Therapeutics Inc | COM | 60040X103 | $521 | 45,101 | 0.3% |
| Surface Oncology Inc | COM | 86877M209 | $221 | 78,300 | 0.1% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $55 | 9,166 | 0.0% |
| Trillium Therapeutics Inc | COM | 89620X506 | $24 | 71,619 | 0.0% |